Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis
Open Access
- 1 July 2002
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 78 (1) , 148-153
- https://doi.org/10.1016/s0015-0282(02)03187-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Thrombospondin-1 Induces Endothelial Cell Apoptosis and Inhibits Angiogenesis by Activating the Caspase Death PathwayJournal of Vascular Research, 2000
- Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancerInternational Journal of Cancer, 1999
- Role of vascular endothelial growth factor in the regulation of angiogenesisKidney International, 1999
- AngiogenesisSeminars in Reproductive Medicine, 1997
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996Fertility and Sterility, 1997
- Manipulating AngiogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium.Journal of Clinical Investigation, 1996
- Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosisHuman Reproduction, 1996
- Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1Science, 1994
- Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro.Proceedings of the National Academy of Sciences, 1991